Simplified quantitative estimation in vitro of lymphocyte radiosensitivity applied to patients with chronic lymphocytic leukaemia

Lymphocyte survival changes observed at 1, 2 and 3 days as responses to 3 doses of ionising radiation in vitro (40, 100, and 500 cGy) are analysed by computer according to a simple (single cell population) mathematical model. Intrinsic radiosensitivity, the susceptibility to lethal injury, which is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia research 1991, Vol.15 (7), p.577-589
Hauptverfasser: Thomson, Alasdair E.R., Wetherley-Mein, Gordon, O'Connor, Thomas W.E., Still, Beverley, Peel, William E., Slater, Nicolas G.P., Bates, Thelma
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lymphocyte survival changes observed at 1, 2 and 3 days as responses to 3 doses of ionising radiation in vitro (40, 100, and 500 cGy) are analysed by computer according to a simple (single cell population) mathematical model. Intrinsic radiosensitivity, the susceptibility to lethal injury, which is expressed as the D 37 value (the radiation dose permitting 37% survival), is estimated separately from the kinetics of subsequent death of lethally-irradiated cells (expressed as their half-life, or t 1 2 value). Among the 35 patients with B-cell CLL studied (15 were never treated), both parameters varied widely and independently of one another, t 1 2 ranged from 9–200 h and above, D 37 from 14–500 cGy or above. Twenty-three patients were deemed ‘radiosensitive’ ( D 37 below 110 cGy). D 37 level did not correlate with treatment status, mode of treatment, clinical staging (Rai) or lymphocyte count. With some exceptions, D 37 remained relatively constant for individual patients with increasing duration of disease or alterations in treatment status. The assay method may prove useful as an aid in predicting response to low-dose splenic irradiation (SI) in CLL.
ISSN:0145-2126
1873-5835
DOI:10.1016/0145-2126(91)90026-P